Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.56 | 0.04 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |